
Sign up to save your podcasts
Or


This month we are joined by Dr Emmanuel Antonarakis, from The University of Minnesota, USA, who discusses the exciting topic of B7-H3 as a New Drug Target in Prostate Cancer. This month is co-chaired by Dr Gert Attard, from The University College London, who leads the question-led disucssion to close the episode.
By Clinical Comms Group5
11 ratings
This month we are joined by Dr Emmanuel Antonarakis, from The University of Minnesota, USA, who discusses the exciting topic of B7-H3 as a New Drug Target in Prostate Cancer. This month is co-chaired by Dr Gert Attard, from The University College London, who leads the question-led disucssion to close the episode.

190 Listeners